జర్నల్ ఆఫ్ ఇన్ఫెక్షియస్ డిసీజెస్ అండ్ థెరపీ

నైరూప్య

Emerging Therapies in Persistent Human Papillomavirus Infections

Nathan Yang, Sennett Yang and Laurel Schwartz

Pharmaceutical companies have developed effective vaccines to prevent certain HPV infections and their associated diseases. However, these vaccine products are not for clearing the persistent HPV infections or curing pre-existing conditions. The unmet needs to treat the diseases, especially cancers, caused by persistent HPV infections remain urgent. Thus, the pharmaceutical industry and multiple medical institutions have invested into developing medications of different modalities, such as viruses, stem cells, T-cells, gene therapies, DNAs, antibodies, antigens, and more. These emerging therapies are the focus of this review.